Ameliora Wealth Management Ltd. Bristol Myers Squibb CO Transaction History

Ameliora Wealth Management Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	BUY	$47.98 - $54.4 $63,429 - $71,916	1,322 Added 4.29%	32,144 $1.74 Billion
Q4 2023 Jan 10, 2024	SELL	$48.48 - $57.85 $466,959 - $557,211	-9,632 Reduced 23.81%	30,822 $1.58 Billion
Q3 2023 Oct 10, 2023	SELL	$57.89 - $64.73 $145,824 - $163,054	-2,519 Reduced 5.86%	40,454 $2.35 Billion
Q2 2023 Jul 10, 2023	BUY	$63.71 - $70.74 $728,269 - $808,628	11,431 Added 36.24%	42,973 $2.75 Billion
Q1 2023 Apr 17, 2023	SELL	$65.71 - $74.53 $231,167 - $262,196	-3,518 Reduced 10.03%	31,542 $2.19 Billion
Q4 2022 Feb 06, 2023	BUY	$68.48 - $81.09 $630,016 - $746,028	9,200 Added 35.58%	35,060 $2.52 Billion
Q3 2022 Nov 07, 2022	BUY	$0.13 - $76.84 $2,477 - $1.46 Million	19,060 Added 280.29%	25,860 $1.79 Million
Q2 2022 Aug 09, 2022	BUY	$72.62 - $79.98 $493,816 - $543,864	6,800 New	6,800 $523,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Ameliora Wealth Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Ameliora Wealth Management Ltd. with notifications on news.